A successful pharmaceutical company for sale in Pennsylvania.
It has developed a product that is very useful for patients as it relieves pain and increases their mobility. According to researches it also modifies osteoarthritis which is expected to affect approximately 500 million people in the next thirty years. This pharmaceutical company for sale has begun Phase-3 clinical trials and has already got several patents. The purpose of this firm is to make its medical product labeled as the modifying agent to treat osteoarthritis making it the first of its kind with drastic improvement within half of a year through the use of 1 IV a year. The testing of this product proved that it is useful in inhibiting and modifying the disease thus slowing and possibly reversing the negative impacts of osteoarthritis. The company for sale operates from a leased facility with a rent of $133. The lease expires 12/2021. Please contact us for further information.